Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Abeona Therapeutics Inc.

NASDAQ: ABEOHealthcare / Biotechnology / USA
8.28+0.31+3.89%Vol 567 8991Y Perf -46.31%
Dec 12th, 2018 16:00
BID8.21 ASK8.79
Open8.00 Previous Close7.97
Pre-Market- After-Trading-
 - -%  - -%
Target Price
26.38 
Analyst Rating
Strong Buy 1.00
Potencial %
218.60 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)397 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
8.90 
Earnings Date
21st Nov 2018

Today's Price Range

8.008.53

 

52wk Range

6.9422.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
3.37%
3 Months
-45.03%
6 Months
-51.70%
1 Year
-46.31%
3 Years
126.42%
5 Years
-45.03%

Quotes

Name / TickerPriceChg.Chg.%
ABEO8.280.31003.89
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
10.90
Current Ratio
11.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-4 502.20
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-843.00
EBITDA Margin
-822.10
Pre-tax Profit Margin
-1 959.60
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.73
PS Ratios
76.66
Price to Cash Flow
30.10
Price to Free Cash Flow
-11.10
Cash Flow Per Share
-0.59
Price to Tangible Book
3.59
Book Value per Share
3.13
Enterprise Value (in ths.)
297 222
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-39.35
ROE last 12 Months
-37.51
Return on Assets (5Y Avg)
-14.33
ROA last 12 Months
-35.14
Return on Capital (5Y Avg)
-
ROC last 12 Months
-38.56
Return on invested Capital Q
-10.87
Return on invested Capital Y
-20.68
Assets Turnover
0.00
Receivables Turnover
12.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
5 341
Revenue per Share
0.11
Revenue Growth 3 Years
41.94
Revenue Growth 5 Years
3.70
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.23-0.34-47.83
Q02 2018-0.16-0.25-56.25
Q01 2018-0.19-0.185.26
Q04 2017-0.13-0.19-46.15
Q03 2017-0.18-0.1327.78
Q02 2017-0.13-0.21-61.54
Q01 2017-0.13-0.130.00
Q04 2016-0.13-0.19-46.15
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.29-52.63Negative
12/2018 FY-0.98-24.05Negative
3/2019 QR-0.185.26Positive
12/2019 FY-1.16-56.76Negative
Next Report Date-
Estimated EPS Next Report-0.23
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume567 899
Shares Outstanding (in ths.)47 940
Trades Count2 625
Dollar Volume4 256 535
Avg. Volume854 107
Avg. Weekly Volume942 235
Avg. Monthly Volume703 569
Avg. Quarterly Volume689 057

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

58%42%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
7 (100.00 %)
8 (88.89 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (11.11 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.11

There are no comments yet.

News